|
MRK's Operating Income Growth by Quarter and Year
Merck And Co Inc 's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| MRK Operating Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
3,094.00
|
-2,249.00
|
2,567.00
|
| III Quarter |
September |
-
|
4,816.00
|
3,116.00
|
2,382.00
|
| II Quarter |
June |
-
|
1,614.00
|
3,129.00
|
3,399.00
|
| I Quarter |
March |
5,569.00
|
3,014.00
|
3,909.00
|
3,255.00
|
| FY |
|
5,569.00
|
12,538.00
|
7,905.00
|
11,603.00
|
| MRK Operating Income first quarter 2022 Y/Y Growth Comment |
Merck and Co Inc achieved in the first quarter 2022, above Company average Operating Income rise of 84.77% year on year, to $ 5,569.00 millions.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Operating Income growth. While Merck And Co Inc ' s Operating Income jump of 84.77% ranks overall at the positon no. 236 in the first quarter 2022.
Explain Operating Income growth
|
| MRK Operating Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
-5.42 % |
| III Quarter |
September |
- |
54.56 % |
30.81 % |
-4.45 % |
| II Quarter |
June |
- |
-48.42 % |
-7.94 % |
66.78 % |
| I Quarter |
March |
84.77 % |
-22.9 % |
20.09 % |
208.82 % |
| FY |
|
- |
58.61 % |
-31.87 % |
39.81 % |
MRK Operating Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-35.76 % |
- |
7.77 % |
| III Quarter |
September |
- |
198.39 % |
-0.42 % |
-29.92 % |
| II Quarter |
June |
- |
-46.45 % |
-19.95 % |
4.42 % |
| I Quarter |
March |
79.99 % |
- |
52.28 % |
19.93 % |
| FY (Year on Year) |
|
- |
58.61 % |
-31.87 % |
39.81 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1067.22 % |
17.92 % |
-89.25 % |
| (Dec. 30, 2008) |
|
(Dec. 30, 2007) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1067.22 % |
17.92 % |
-89.25 % |
| (Dec. 30, 2008) |
|
(Dec. 30, 2007) |
|
| Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1532.46 % |
37.74 % |
-95.43 % |
| (Dec 31 2017) |
|
|
| MRK's I. Quarter Q/Q Operating Income Comment |
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 79.99%, to $ 5,569.00 millions, from $3,094.00 millions in the forth quarter.
Merck And Co Inc is impressively improving, not only reporting above regular increase, but also accelerating speed.
Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 177. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 1532.46 % |
37.74 % |
-95.43 % |
| (Dec 31 2017) |
|
|
| MRK's I. Quarter Q/Q Operating Income Comment |
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 79.99%, to $ 5,569.00 millions, from $3,094.00 millions in the forth quarter.
Major Pharmaceutical Preparations company is undergoing a remarkable growth, not only claiming higher then average increase, and also improving pace.
Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 177. |
|
Merck And Co Inc 's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Operating Income 12 Months Ending |
$ 15,093.00 |
$ 12,538.00 |
$ 7,195.00 |
$ 5,495.00 |
$ 7,010.00 |
| Y / Y Operating Income Growth (TTM) |
115.31 % |
58.61 % |
-43.44 % |
-54.16 % |
-42.81 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 253 |
# 479 |
# 1898 |
# 1985 |
# 1482 |
| Seqeuential Operating Income Change (TTM) |
20.38 % |
74.26 % |
30.94 % |
-21.61 % |
-11.32 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 236 |
# 208 |
# 376 |
# 2000 |
# 387 |
| Cumulative Operating Income growth
Comment |
Merck And Co Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 115.31% year on year, to $ 15,093 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Operating Income growth was higher than company's average 59.76% and higher than 58.61% growth in Dec 31 2021.
But sequential growth rate was slower at 20.38 % from $12538 millions recorded in twelve months ending a quarter Dec 31 2021 Alexander P. Robinson added on.
Yet this was evidence of strength, as the average sequential advancement stands at 17.92%.
The progress is even stronger sequentially exhibited at 20.38 % increase from $12538 millions in the period from Dec 31 2021 to Mar 31 2021.
Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 253, from total ranking in previous quarter at 479. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1067.22 % |
17.92 % |
-89.25 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1129.36 % |
59.76 % |
-89.44 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 6 |
| Sector |
# 13 |
| S&P 500 |
# 236 |
|
| Cumulative Operating Income growth
Comment |
Merck And Co Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 115.31% year on year, to $ 15,093 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Operating Income growth was higher than company's average 59.76% and higher than 58.61% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 increase was beneth at 20.38 % from $12538 millions achieved in twelve months ending a quarter before.
In spite of, this was evidence of strength, while the usual Q/Q TTM gain lays at 17.92%.
The growth is even higher sequentially showed at 20.38 % increase from $12538 millions in the period from Dec 31 2021 to Mar 31 2021.
Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 253, from total ranking in previous quarter at 479. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1067.22 % |
17.92 % |
-89.25 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1129.36 % |
59.76 % |
-89.44 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 6 |
| Sector |
# 13 |
| S&P 500 |
# 236 |
|
132.52%